Funder
Hamadan University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. D.A. Guertin, D.M. Sabatini, in: J. Mendelsohn, P.M. Howley, M.A. Israel, J.W. Gray, C.B. Thompson, (Eds.), The Molecular Basis of Cancer (Third Edition), W.B. Saunders, Philadelphia, 2008.
2. F. Sadoughi, P.M. Dana, Z. Asemi, B. Yousefi, DNA damage response and repair in osteosarcoma: defects, regulation and therapeutic implications. DNA Repair 102, 103105 (2021). https://doi.org/10.1016/j.dnarep.2021.103105
3. Y.J. Luo, B.L. Wang, S.B. Kou, Z.Y. Lin, K.L. Zhou, Y.Y. Lou, J.H. Shi, Assessment on the binding characteristics of dasatinib, a tyrosine kinase inhibitor to calf thymus DNA: insights from multi-spectroscopic methodologies and molecular docking as well as DFT calculation. J. Biomol. Struct. Dyn. 38(14), 4210–4220 (2020). https://doi.org/10.1080/07391102.2019.1676824
4. A. Mukherjee, W.D. Sasikala, Drug–DNA intercalation: From discovery to the molecular mechanism. Adv. Protein Chem. Struct. Biol. 92, 1–62 (2013). https://doi.org/10.1016/B978-0-12-411636-8.00001-8
5. M.J. Lind, Principles of systemic anticancer therapy. Medicine 48(2), 90–96 (2020). https://doi.org/10.1016/j.mpmed.2019.11.005
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献